SNPS Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Given the user's beginner investment level, long-term strategy, and available capital, Synopsys Inc. (SNPS) is not a strong buy at the moment. The stock is currently facing bearish technical indicators, mixed analyst sentiment, and declining financial performance. While there are some positive catalysts, such as congress members' purchases and share repurchase programs, the lack of strong growth signals and limited near-term catalysts suggest holding off on buying for now.
The technical indicators for SNPS are mixed to bearish. The MACD is positive and expanding, indicating potential upward momentum, but the RSI is neutral at 54.622, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). Key support and resistance levels suggest the stock is trading near resistance (R1: 448.881) and could face downward pressure. The stock is currently trading at $438.705, down 0.85% in the regular market.
Congress members have made two recent purchase transactions, indicating confidence in the stock.
Synopsys approved a $2 billion stock repurchase program, reflecting management's confidence in the company's value.
Partnerships, such as with Innatera for low-power AI chip design, highlight Synopsys' focus on innovation and AI-driven opportunities.
Hedge funds are selling the stock, with a 427.09% increase in selling activity over the last quarter.
Analysts have downgraded the stock, citing decelerating growth in electronic design automation and muted revenue growth in FY
Financial performance in Q1 2026 showed a significant decline in net income (-78.03% YoY) and EPS (-82.01% YoY), with gross margin also dropping by 17.38%.
In Q1 2026, Synopsys reported a 65.52% YoY increase in revenue to $2.41 billion. However, net income dropped by 78.03% YoY to $64.96 million, and EPS fell by 82.01% YoY to $0.34. Gross margin also declined to 67.06%, down 17.38% YoY. These results indicate strong top-line growth but significant challenges in profitability and cost management.
Analyst sentiment is mixed to negative. Recent downgrades include Morgan Stanley lowering the rating to Equal Weight with a $480 price target and HSBC downgrading to Hold with a $455 price target. Analysts cite decelerating growth in electronic design automation, muted revenue growth in FY26, and geopolitical uncertainties. However, some analysts remain optimistic about long-term growth, with JPMorgan maintaining an Overweight rating and a $650 price target.
